271 related articles for article (PubMed ID: 30206805)
21. Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study.
He S; Ji D; Liu Y; Deng X; Zou W; Liang D; Du Y; Zong K; Jiang T; Li M; Zhang D; Yue X; Tao F; Cao Y; Liang C
J Assist Reprod Genet; 2023 Aug; 40(8):1983-1993. PubMed ID: 37358742
[TBL] [Abstract][Full Text] [Related]
22. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
Bicer M; Alan M; Alarslan P; Guler A; Kocabas GU; Imamoglu C; Aksit M; Bozkaya G; Isil AM; Baloglu A; Aslanipoiur B; Calan M
J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
[TBL] [Abstract][Full Text] [Related]
23. Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS.
He Y; Hu W; Yang G; Guo H; Liu H; Li L
Biomed Res Int; 2020; 2020():1253164. PubMed ID: 32076603
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Harsha Varma S; Tirupati S; Pradeep TVS; Sarathi V; Kumar D
Diabetes Metab Syndr; 2019; 13(2):1065-1069. PubMed ID: 31336445
[TBL] [Abstract][Full Text] [Related]
25. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
27. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
29. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
Gursoy Calan O; Calan M; Yesil Senses P; Unal Kocabas G; Ozden E; Sari KR; Kocar M; Imamoglu C; Senses YM; Bozkaya G; Bilgir O
Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
[TBL] [Abstract][Full Text] [Related]
30. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
31. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
[TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients.
Oztas E; Ozler S; Tokmak A; Yilmaz N; Celik HT; Kazancı FH; Danisman N; Ergin M; Yakut HI
Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():89-93. PubMed ID: 26802256
[TBL] [Abstract][Full Text] [Related]
34. Polycystic ovary syndrome and the metabolic syndrome.
Weerakiet S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
[TBL] [Abstract][Full Text] [Related]
35. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.
Gupta V; Mishra S; Mishra S; Gupta V
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S697-S701. PubMed ID: 28529126
[TBL] [Abstract][Full Text] [Related]
36. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
[TBL] [Abstract][Full Text] [Related]
37. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.
Alebić MŠ; Bulum T; Stojanović N; Duvnjak L
Endocrine; 2014 Nov; 47(2):625-30. PubMed ID: 24522614
[TBL] [Abstract][Full Text] [Related]
38. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
Barrea L; Arnone A; Annunziata G; Muscogiuri G; Laudisio D; Salzano C; Pugliese G; Colao A; Savastano S
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547562
[TBL] [Abstract][Full Text] [Related]
39. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
[TBL] [Abstract][Full Text] [Related]
40. Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients.
Wanderley MDS; Pereira LCR; Santos CB; Cunha VSD; Neves MVJ
Rev Bras Ginecol Obstet; 2018 Apr; 40(4):188-195. PubMed ID: 29747212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
